AMC: Analysts Call For EPS Of -$0.19 In Q2

AMC Entertainment Holdings, Inc. (NYSE: AMC) will report its second quarter financial results on August 4th after market close. Analysts have a consensus $9.09 12-month price target on the company, via a total of 8 analysts, with 3 analysts having hold ratings, 3 analysts have sell ratings and the last 2 analysts have strong sell ratings on the stock.

Seven analysts have revenue estimates for the second quarter. The mean revenue estimate between all seven analysts is $1.18 billion; this number has been revised downwards from $1.25 billion at the start of the year. The highest revenue estimate is $1.28 billion, while the lowest is $1.1 billion.

Onto EBITDA estimates, there are currently seven analysts who have second quarter EBITDA estimates. The mean is currently $78.9 million, with this number having been revised downwards from $148 million at the start of the year. Street high is a $126.6 million EBITDA estimate and the lowest is $15.9 million.

Analysts estimate that quarterly earnings per share will come in at -$0.19, with this number being revised downwards from -$0.11 at the start of the year. The street high estimate is -$0.09 and the lowest estimate is -$0.36 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Hidden Environmental Cost of Fertilizer | Robin Dow

Could Silver Stay This High? | Joaquín Marias – Argenta Silver

Can Historic Silver Data Turn Into a New Mine? | Rob Macdonald – Equity Metals

Recommended

Ottawa Backs First Phosphate Battery Grade Validation Push With $16.7M Boost

First Majestic Drills 3.43 g/t Gold Over 24.4 Metres At Jerritt Canyon

Related News

Facebook: Analysts Expect $3.03 In Q2 Earnings Per Share

Facebook (NASDAQ: FB) will be reporting its second quarter financial results today after the markets...

Wednesday, July 28, 2021, 11:20:00 AM

Canaccord Slashes Antibe Therapeutics Price Target A Month After Drug Trial Paused

On August 3, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Wednesday, September 29, 2021, 11:44:00 AM

Hexo Corp: Canaccord Cuts Target To $0.25 After Guidance Withdrawal

Earlier this week Hexo Corp (TSX: HEXO) reported its fiscal third-quarter ending April 30th. The...

Thursday, June 16, 2022, 04:32:00 PM

First Majestic: BMO Cuts Target To $9.50

Last week First Majestic Silver Corp (TSX: FR) announced its second quarter production results. The...

Thursday, July 28, 2022, 04:46:00 PM

K92 Mining: Canaccord Initiates Coverage With $8.75 Price Target

On January 31st, Canaccord Genuity Capital Markets initiated coverage on K92 Mining Inc. (TSX: KNT),...

Thursday, February 3, 2022, 04:29:00 PM